GREENLAND MINES LTD
GRMLNASDAQπ #4799 by market capUS Equity
$2.98β² $0.04 (+1.53%)
Market closed Β· at closeTrack GRML
Get earnings, price moves & breaking news on Telegram
24hβ² 1.5%
7dβΌ 17.6%
14dβΌ 22.4%
30dβΌ 48.4%
ytdβΌ 79.2%
1yβΌ 87.1%
π¦Market Cap
$9M
Small Cap
πRevenue Growth (YoY)
0.0%
Slowing
πGross Margin
0.0%
Thin
π΅FCF Margin
0.0%
Thin
βοΈP/S Ratio
0.0x
Cheap
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $2.78 β $3.09
- 52-Week Range
- $0.16 β $18.08
- Volume (shares)
- 11,612
- Avg Volume (shares)
- β
- Shares Outstanding
- 3.0M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- -0.2
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-12.85
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +167.9%
GREENLAND MINES LTD
GRMLFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$7Mβ² +29.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$6Mβ² +107.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
1.5Mβ² +167.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7Mβ² +$7M YoY
About GREENLAND MINES LTD
Greenland Mines Ltd. (GRML) focuses on developing innovative therapeutic solutions to combat neurodegenerative diseases. The company's primary treatment modalities involve cutting-edge cell and gene therapies. Joseph Sinkule founded this enterprise on August 2, 2004, and its corporate operations are based in Omaha, Nebraska.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.